SCHEMBL7074124

SCHEMBL7074124

O=C(CN1C=CSC1)c1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
PTPN1 P18031 1/20 0.43
TSHR P16473 3/20 0.42
HTT P42858 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
SIGMAR1 Q99720 2/20 0.40
SLC18A3 Q16572 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2B Q13224 1/20 0.40
HTR7 P34969 1/20 0.39
PLOD2 O00469 1/20 0.39
IDO1 P14902 1/20 0.39
HTR2A P28223 2/20 0.39
HTR2C P28335 2/20 0.39
POLB P06746 1/20 0.39
KCNH2 Q12809 1/20 0.39
KMT2A Q03164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3847336 0.98 NPC1 (0.42) NPC1RAB9APTPN1TSHRHTT
SCHEMBL6936037 0.84 GSK3B (0.44) NPC1RAB9ATSHRHTTSMN1; SMN2
SCHEMBL6935144 0.84 GSK3B (0.44) RAB9AHTTSMN1; SMN2ALDH1A1KMT2A
Bromide SCHEMBL4114709 0.83 RAB9A (0.46) NPC1RAB9ATSHRHTTSMN1; SMN2
Bromide SCHEMBL2947798 0.83 RAB9A (0.46) RAB9AHTTSMN1; SMN2ALDH1A1KMT2A
Bromide SCHEMBL122634 0.83 ALDH1A1 (0.43) NPC1RAB9APTPN1SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL4019649 0.83 ALDH1A1 (0.43) RAB9APTPN1SMN1; SMN2ALDH1A1KDM4E
Bromide SCHEMBL7402289 0.83 ALDH1A1 (0.43) NPC1RAB9APTPN1SMN1; SMN2ALDH1A1
SCHEMBL8390047 0.81 ALDH1A1 (0.52) NPC1RAB9AHTTALDH1A1KDM4E
SCHEMBL8387913 0.81 CES2 (0.45) RAB9AHTR2AHTR2CKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808163-B1 USE OF THIAZOLIUM COMPOUNDS FOR PREVENTING AND REVERSING THE FORMATION OF ADVANCED GLYCOSYLATION ENDPRODUCTS ALTEON INC (US) 2003-07-23 EP claimed